🇺🇸 Magnesium sulfate administration in United States

4 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 4

Most-reported reactions

1. Hypocalcaemia — 1 report (25%)
2. Hypokalaemia — 1 report (25%)
3. Hypomagnesaemia — 1 report (25%)
4. Urinary Tract Infection — 1 report (25%)

Source database →

Frequently asked questions

Is Magnesium sulfate administration approved in United States?

Magnesium sulfate administration does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Magnesium sulfate administration in United States?

University of California, San Francisco is the originator. The local marketing authorisation holder may differ — check the official source linked above.